Intradiscal Steroid Temporarily Alleviates Lower Back Pain
|
By HospiMedica International staff writers Posted on 06 Apr 2017 |
A single intradiscal injection of glucocorticoid (GC) is associated with reduced short-term low back pain (LBP) in patients with active discopathy, according to a new study.
Researchers at Université Paris Descartes, Hôpital Roger Salengro, and other institutions conducted a prospective, randomized, controlled study involving 135 patients with chronic LBP with active discopathy as demonstrated on magnetic resonance imaging (MRI), treated at three tertiary care centers in France. Study patients received a single GC intradiscal injection of 25 mg prednisolone acetate during discography (67 patients), while control patients underwent discography alone (68 patients).
The researchers found that percentage of patients with LBP intensity lower than 40 on an 11-point numerical rating scale was higher in the study group than the control group at one month after the intervention (55.4% versus 33.3%, respectively); there was no between-group difference in LBP intensity at 12 months. Secondary outcomes, such as spine-specific limitations in activities, health-related quality of life, anxiety and depression, employment status, and analgesic use did not differ between the groups at one or 12 months. The study was published on March 21, 2017, in Annals of Internal Medicine.
“Our results do not support the wide use of an injection of glucocorticoid in alleviating symptoms in the long term in this condition; the findings are consistent with earlier studies,” concluded lead Christelle Nguyen, MD, PhD, of Paris Descartes University, and colleagues. “Patients who did or didn't receive a steroid injection ended up in similar circumstances, with the same incidence of disc inflammation, lower quality of life, more anxiety and depression, and continued use of non-narcotic pain pills.”
Many spinal conditions, including a lumbar herniated disc, can cause inflammation or pressure on the nerve roots leading out of the spine, resulting in pain, tingling, or numbness. A lumbar epidural GC injection may be used to reduce the inflammation around the spinal nerves. But studies have shown that epidural steroid injections play a limited role in providing short-term pain relief, with an average time of two to six weeks after injection.
Researchers at Université Paris Descartes, Hôpital Roger Salengro, and other institutions conducted a prospective, randomized, controlled study involving 135 patients with chronic LBP with active discopathy as demonstrated on magnetic resonance imaging (MRI), treated at three tertiary care centers in France. Study patients received a single GC intradiscal injection of 25 mg prednisolone acetate during discography (67 patients), while control patients underwent discography alone (68 patients).
The researchers found that percentage of patients with LBP intensity lower than 40 on an 11-point numerical rating scale was higher in the study group than the control group at one month after the intervention (55.4% versus 33.3%, respectively); there was no between-group difference in LBP intensity at 12 months. Secondary outcomes, such as spine-specific limitations in activities, health-related quality of life, anxiety and depression, employment status, and analgesic use did not differ between the groups at one or 12 months. The study was published on March 21, 2017, in Annals of Internal Medicine.
“Our results do not support the wide use of an injection of glucocorticoid in alleviating symptoms in the long term in this condition; the findings are consistent with earlier studies,” concluded lead Christelle Nguyen, MD, PhD, of Paris Descartes University, and colleagues. “Patients who did or didn't receive a steroid injection ended up in similar circumstances, with the same incidence of disc inflammation, lower quality of life, more anxiety and depression, and continued use of non-narcotic pain pills.”
Many spinal conditions, including a lumbar herniated disc, can cause inflammation or pressure on the nerve roots leading out of the spine, resulting in pain, tingling, or numbness. A lumbar epidural GC injection may be used to reduce the inflammation around the spinal nerves. But studies have shown that epidural steroid injections play a limited role in providing short-term pain relief, with an average time of two to six weeks after injection.
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







